Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction.

The human mu opioid receptor (MOR) plays a central role in mediating the effects of opioids, both endogenous and exogenous. Epidemiological studies have shown that addiction in general, and especially opiate addiction, has a heritable component. Clinical and laboratory studies suggest that the MOR gene may contribute to the heritable component of vulnerability to develop opiate addiction. Naturally occurring single nucleotide polymorphisms (SNPs) have been identified in the MOR gene by conventional methods. Two coding region SNPs, the A118G and C17T substitutions, occur at high allelic frequencies (10.5% and 6.6%, respectively, in our previous studies). These common SNPs cause amino acid changes in the receptor, and may have implications for differences in individual responses to opioids, as well as decreased or increased vulnerability to opiate addiction. The A118G substitution encodes a variant receptor with binding and signal transduction differences in response to beta-endorphin in cellular assays. Recent innovations in microchip technology offer new potential methods for SNP detection. We report here on the development of two separate approaches using custom oligonucleotide gelpad microarrays for detection of these two common SNPs of the MOR gene in human DNA samples. First, PCR-amplified genomic DNA samples were used to produce target sequences, which were labeled with fluorescent dye and hybridized to custom microchips. Oligonucleotides on these reusable microchips were designed to query nucleotide substitutions at positions 17 and 118 of the MOR gene. Thirty-six human DNA samples were assayed both on these custom microchips and by conventional automated gel sequencing, with highly concordant identification of both heterozygous and homozygous substitutions. A second approach was developed for the C17T SNP utilizing single nucleotide extension on custom microchips. These custom gelpad microchips have potential for the rapid and inexpensive detection of specific SNPs for genetic and genomic studies.

[1]  J. Gelernter,et al.  Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1). , 1998, Alcoholism, clinical and experimental research.

[2]  K. Kendler,et al.  Cocaine use, abuse and dependence in a population-based sample of female twins , 1998, British Journal of Psychiatry.

[3]  M. Hoehe,et al.  The human µ opioid receptor gene: 5´ regulatory and intronic sequences , 1998, Journal of Molecular Medicine.

[4]  A. Mirzabekov,et al.  DNA sequencing by hybridization to microchip octa-and decanucleotides extended by stacked pentanucleotides. , 1996, Nucleic acids research.

[5]  W. Berrettini,et al.  Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse , 1997, Addiction biology.

[6]  A. Frantz,et al.  EFFECTS OF CHRONIC EXOGENOUS OPIOID ADMINISTRATION ON LEVELS OF ONE ENDOGENOUS OPIOID (β-ENDORPHIN) IN MAN , 1981 .

[7]  H. Jansen,et al.  Altered Hematopoiesis, Behavior, and Sexual Function in μ Opioid Receptor–deficient Mice , 1997, The Journal of experimental medicine.

[8]  G. Pasternak Pharmacological mechanisms of opioid analgesics. , 1993, Clinical neuropharmacology.

[9]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[10]  A. Mirzabekov,et al.  Immobilization of DNA in polyacrylamide gel for the manufacture of DNA and DNA-oligonucleotide microchips. , 1998, Analytical biochemistry.

[11]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[12]  W. Vogel,et al.  Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains , 1994, Nature Genetics.

[13]  K. Itakura,et al.  Detection of sickle cell beta S-globin allele by hybridization with synthetic oligonucleotides. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Mirzabekov,et al.  Parallel thermodynamic analysis of duplexes on oligodeoxyribonucleotide microchips. , 1998, Nucleic acids research.

[15]  X. Estivill,et al.  SSCP analysis: A blind sensitivity trial , 1997, Human mutation.

[16]  M. Kreek,et al.  CHRONIC USE OF OPIOIDS AND ANTIPSYCHOTIC DRUGS: SIDE EFFECTS, EFFECTS ON ENDOGENOUS OPIOIDS, AND TOXICITY * , 1982, Annals of the New York Academy of Sciences.

[17]  L Peltonen,et al.  Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. , 1997, Genome research.

[18]  B. Mason,et al.  A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. , 1994, Alcoholism, clinical and experimental research.

[19]  K Kontula,et al.  A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. , 1990, Genomics.

[20]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[21]  G F Koob,et al.  Drug dependence: stress and dysregulation of brain reward pathways. , 1998, Drug and alcohol dependence.

[22]  L. Peltonen,et al.  Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. , 1998, Human molecular genetics.

[23]  H. Schulman,et al.  The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  J. Long,et al.  μ opioid receptor gene variants: lack of association with alcohol dependence , 1997, Molecular Psychiatry.

[25]  N. Chiorazzi,et al.  Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. , 1989, The Journal of pharmacology and experimental therapeutics.

[26]  M. Kreek,et al.  Chronic cocaine alters brain mu opioid receptors , 1992, Brain Research.

[27]  M. Tsuang,et al.  Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. , 1998, Archives of general psychiatry.

[28]  S. P. Fodor,et al.  Light-directed, spatially addressable parallel chemical synthesis. , 1991, Science.

[29]  S. Faraone,et al.  Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. , 1996, American journal of medical genetics.

[30]  J A Tischfield,et al.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Grompe,et al.  The rapid detection of unknown mutations in nucleic acids , 1993, Nature genetics.

[32]  C. Kozak,et al.  Murine chromosomal location of the mu and kappa opioid receptor genes. , 1994, Genomics.

[33]  D. Lykken,et al.  Heterogeneity in the inheritance of alcoholism. A study of male and female twins. , 1991, Archives of general psychiatry.

[34]  M. Kreek,et al.  MEDICAL COMPLICATIONS IN METHADONE PATIENTS * , 1978, Annals of the New York Academy of Sciences.

[35]  C. Robert Cloninger,et al.  Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. , 1981, Archives of general psychiatry.

[36]  D. Yandell,et al.  How sensitive is PCR‐SSCP? , 1993, Human mutation.

[37]  J. Crabbe,et al.  Identifying genes for alcohol and drug sensitivity: recent progress and future directions , 1999, Trends in Neurosciences.

[38]  M. Kreek Long-Term Pharmacotherapy for Opiate (Primarily Heroin) Addiction: Opioid Antagonists and Partial Agonists , 1996 .

[39]  R. Cadoret,et al.  Adoption study demonstrating two genetic pathways to drug abuse. , 1995, Archives of general psychiatry.

[40]  Lysov YuP,et al.  A method for DNA sequencing by hybridization with oligonucleotide matrix. , 1991, DNA sequence : the journal of DNA sequencing and mapping.

[41]  B. Cox,et al.  Effect of Chronic Cocaine Treatment on μ‐ and δ‐Opioid Receptor mRNA Levels in Dopaminergically Innervated Brain Regions , 1996 .

[42]  James L. Winkler,et al.  Accessing Genetic Information with High-Density DNA Arrays , 1996, Science.

[43]  N. Shen,et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.

[44]  L. Bare,et al.  Expression of two variants of the human μ opioid receptor mRNA in SK‐N‐SH cells and human brain , 1994, FEBS letters.

[45]  M. Kreek,et al.  Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. , 1998, Alcoholism, clinical and experimental research.

[46]  S. O’Brien,et al.  Detecting single base substitutions as heteroduplex polymorphisms. , 1992, Genomics.

[47]  Robert F. Dannals,et al.  Increased mu opioid receptor binding detected by PET in cocaine–dependent men is associated with cocaine craving , 1996, Nature Medicine.

[48]  A. Cavalli,et al.  mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. , 1998, Brain research. Molecular brain research.

[49]  A. Mirzabekov,et al.  Sequence analysis by hybridization with oligonucleotide microchip: identification of beta-thalassemia mutations. , 1997, Gene.

[50]  H. Takagi Advances in Endogenous and Exogenous Opioids , 1982 .

[51]  W. Vogel,et al.  Further evidence for a quantitative trait locus on murine chromosome 10 controlling morphine preference in inbred mice , 1996, Psychiatric genetics.

[52]  J. Belknap,et al.  The genetics of pain and pain inhibition. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Khrapko,et al.  An oligonucleotide hybridization approach to DNA sequencing , 1989, FEBS letters.

[54]  B. Rounsaville,et al.  Naltrexone and coping skills therapy for alcohol dependence. A controlled study. , 1992, Archives of general psychiatry.

[55]  E. Ochoa Mangado [Naltrexone in the treatment of alcohol dependence]. , 1998, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines.

[56]  K. Hayashi,et al.  PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. , 1991, PCR methods and applications.

[57]  S. Bergeson,et al.  Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains. , 1995, Life sciences.

[58]  S. P. Fodor,et al.  Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysis , 1996, Nature Genetics.

[59]  A. Mirzabekov,et al.  DNA analysis and diagnostics on oligonucleotide microchips. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Kreek Long-Term Pharmacotherapy for Opiate (Primarily Heroin) Addiction: Opioid Agonists , 1996 .

[61]  V. Yuferov,et al.  Acute “binge” cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system , 1999, Brain Research Bulletin.

[62]  E. Southern,et al.  Analyzing and comparing nucleic acid sequences by hybridization to arrays of oligonucleotides: evaluation using experimental models. , 1992, Genomics.

[63]  A. Mirzabekov,et al.  Polymorphism analysis and gene detection by minisequencing on an array of gel-immobilized primers. , 1999, Nucleic acids research.

[64]  I. Sora,et al.  Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[65]  A. Syvänen From gels to chips: “Minisequencing” primer extension for analysis of point mutations and single nucleotide polymorphisms , 1999, Human mutation.

[66]  M. Smolka,et al.  Human μ‐Opioid Receptor Variation and Alcohol Dependence , 1998 .

[67]  C. Nusbaum,et al.  Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. , 1998, Science.

[68]  J. Crabbe,et al.  Chromosome Mapping of Gene Loci Affecting Morphine and Amphetamine Responses in BXD Recombinant Inbred Mice a , 1992, Annals of the New York Academy of Sciences.

[69]  M. Kreek Medical safety and side effects of methadone in tolerant individuals. , 1991, Journal of psychoactive drugs.

[70]  I. Sora,et al.  The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Schuster,et al.  Pharmacological aspects of drug dependence: toward an integrated neurobehavioral approach. , 1996 .

[72]  L. Bierut,et al.  Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. , 1998, Archives of general psychiatry.

[73]  B. K. Pal,et al.  Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[74]  M. Kreek Opiates, opioids and addiction. , 1996, Molecular psychiatry.

[75]  M. Kreek,et al.  Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. , 1994, Neuroreport.

[76]  G. Uhl,et al.  Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. , 1994, FEBS letters.

[77]  K. Merikangas,et al.  Familial transmission of substance use disorders. , 1998, Archives of general psychiatry.

[78]  J. Culpepper-Morgan,et al.  Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal. , 1997, Metabolism: clinical and experimental.

[79]  E. Lander,et al.  Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999 .

[80]  V. Florentiev,et al.  Regioselective immobilization of short oligonucleotides to acrylic copolymer gels. , 1996, Nucleic acids research.

[81]  C. Bottema,et al.  Characterization of polymerase chain reaction amplification of specific alleles. , 1990, Analytical biochemistry.

[82]  Dole Vp,et al.  Narcotic blockade. 1966. , 1991 .

[83]  Brigitte L. Kieffer,et al.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene , 1996, Nature.

[84]  K. Kendler,et al.  Hallucinogen, opiate, sedative and stimulant use and abuse in a population‐based sample of female twins , 1999, Acta psychiatrica Scandinavica.

[85]  A. Mirzabekov,et al.  Manual manufacturing of oligonucleotide, DNA, and protein microchips. , 1997, Analytical biochemistry.

[86]  M. Kreek,et al.  NALOXONE, A SPECIFIC OPIOID ANTAGONIST, REVERSES CHRONIC IDIOPATHIC CONSTIPATION , 1983, The Lancet.

[87]  M. Kreek,et al.  Narcotic blockade. , 1966, Archives of internal medicine.

[88]  B. Mason,et al.  A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence , 1994 .

[89]  S. Green,et al.  Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. , 1994, Biochemistry.